Figure 1, S2, S22, S23 clinical source data.xlsx

Figure 1: The expression of pACLY Tyr542, Tyr652, and pALDOA Tyr174, Tyr302, or Tyr328 in sequential slices of 55 ESCC tumor tissues and 10 normal tissues.Figure S2 and S22: The expression of pFAK Tyr576/577, pSrc Tyr419, pFyn Tyr420, pLyn Tyr397, pACLY Tyr542, Tyr652, and pALDOA Tyr174, Tyr302, or Tyr328 with MCM3, MCM4, MCM5, MCM6, MCM7, CDC45, CCND1, CCNE1, CDK7, and CDK9 in sequential slices of primary ESCC tissues (approximately n = 18).Figure S2 and S23: The expression of pFAK Tyr576/577, pSrc Tyr419, pFyn Tyr420, pLyn Tyr397, pACLY Tyr542, Tyr652, and pALDOA Tyr174, Tyr302, or Tyr328 with SDC2, ITGA5, GALK1, FGF2, AXL, MMP14, TWIST1, c-Myc, Sox2, and Oct4 in sequential slices of metastatic lymph nodes (approximately n = 20).